Professional Services Professional Services & Outsourcing Research & Intellectual Property

R&D Partnerships

SRI International Battelle Southwest Research Institute SAIC
Inside this journey
  1. Customer Discovery

    Align on program triggers, required accreditations, IP concerns, key stakeholders, success signals, and schedule/budget constraints.

    Discovery Questions

    Tell Us About Your Program

    • What is the program or contract name and a one-line objective we should keep front of mind?
    • What is your role and how involved will you be in day-to-day decisions for this engagement? Options: VP/R&D, CTO/Head of Tech, Program Manager, Director/Principal Investigator, Procurement/Contracts, Other
    • What triggered the need for an external research partner today? Options: Contract requirement / accreditation, Internal R&D gap, Competitive bid/subcontract need, Timeline risk on internal effort, Regulatory/test need, Other
    • How urgent is this work on a scale of practical priority? Options: Must deliver to next contract milestone (critical), High priority within 3 months, Planned within 3–6 months, Exploratory—no immediate deadline
    • Which technical areas best describe the work you expect (pick all that apply)? Options: Materials science, Autonomous systems/controls, Energy storage/power, Biosciences/assay development, Advanced computing/ML, Systems integration, Other
    • Have you tried to solve this internally or with other partners before? Briefly describe what happened.

    What’s Kept You Up at Night About This Program?

    • If this program misses its goals, what will the real cost be—for the budget, the timeline, and for the team’s credibility?
    • What are the single biggest technical unknowns or failure modes that keep you worried?
    • Which of these failure modes is most likely to happen based on prior evidence? Options: Scale-up/manufacturability, Test reproducibility, Materials performance, Integration with existing systems, Data quality/validation, Regulatory/compliance
    • How do past program overruns or technical surprises still influence how you evaluate outside partners?
    • On a scale from 1–5, how much psychological pressure is there to deliver—are leaders watching daily, weekly, or only at milestones? Options: 1 - Low (leaders see milestones only), 2 - Low–moderate, 3 - Moderate (regular updates), 4 - High (leadership checks frequently), 5 - Very high (daily/near-daily scrutiny)
    • How do you emotionally weigh the choice between a fast hopeful prototype and a slower, risk‑reduced experiment?

    Who Will Be Cheering—or Blaming—When This Delivers?

    • Who are the stakeholders who must be convinced for this to move from pilot → funded program → deployment? Options: Program Manager, VP/Director of R&D, Procurement/Contracts, Regulatory/Compliance Lead, Manufacturing/Operations, External customer/Prime contractor, Other
    • Who has final authority to select a research partner and sign the SOW or contract? Options: Program Manager, VP/Director, Procurement/Contracts, Legal with stakeholder sign-off, Other
    • Which internal teams will need to provide inputs, samples, or access during the pilot? Options: Systems engineering, Manufacturing, IT/security, QA/regulatory, Logistics, None / fully external
    • How often have key stakeholders shifted priorities mid‑program in the past 24 months? Options: Never, Rarely, Occasionally, Often, Almost always
    • Tell us about one example where stakeholder misalignment cost time or budget—what happened and what would you change?
    • How important is having a named technical lead from our side stay for the program duration? Options: Essential, Important but negotiable, Preferable, Not important

    Is the Timeline Real—or a Hopeful Target?

    • Was the project timeline set to win a bid, meet a contract milestone, or to reflect technical de‑risking needs? Options: Set to win a bid, Set to meet contract milestone, Set based on technical de‑risking needs, Mixed/uncertain
    • Which dates are truly immovable (e.g., government deliverable, regulatory deadline)?
    • How much contingency is budgeted for schedule slips? Options: None, Small (≤10%), Moderate (10–25%), Significant (>25%)
    • When your teams have missed schedules previously, what was the primary cause? Options: Technical complexity, Staffing turnover, Procurement delays, Scope creep, Regulatory/clearance delays, Other
    • If a pilot today revealed a new, costly risk, what is the decision path for buying more time or money?
    • How would missing the next milestone change your organization’s next steps or funding posture?

    Intellectual Property, Data & Controls — Where Are You Willing To Compromise?

    • If forced to choose, would you prioritize retaining broad commercialization rights or getting faster, more open collaboration during pilot work? Options: Retain full commercialization rights, Shared/licensing model acceptable, Faster collaboration with limited IP rights, Undecided
    • Which IP frameworks are acceptable to you (pick all that apply)? Options: Client retains all IP, Joint ownership, Client exclusive license, Non-exclusive license, Background IP retained by each party, Other
    • Are there data residency, export control, or classification constraints we must meet? Options: ITAR/EAR, Controlled Unclassified Information (CUI), FDA/regulatory data constraints, GDPR/personal data, No special constraints, Other
    • What contract terms feel like instant deal‑killers to you on IP or publication rights?
    • How do you prefer raw experimental data be delivered and archived? Options: Raw datasets + metadata, Curated reports with appendices, Both raw and curated, Only summary reports
    • Have you previously negotiated a sponsored research arrangement—what lessons should we know up front?

    What Will ‘Success’ Actually Look Like to Your Team?

    • Imagine the pilot is complete and you are thrilled—what measurable signals led to that feeling?
    • Which of the following acceptance criteria must be met for you to consider the pilot successful? Options: Specific performance thresholds met, Reproducible test results, Scalability demonstration, Passing independent accredited tests, Clear path to commercialization, Other
    • What tests, standards, or accreditation bodies do we need to demonstrate compliance with? Options: ISO standards, Third‑party accredited lab, Government/regulatory test protocol, Pharma-specific assays / GLP, Custom client protocol, None specified
    • Who signs off on the Go/No‑Go after the pilot, and what evidence do they require? Options: Program Manager, VP/Director, Technical review board, External customer/prime, Other
    • What downstream outcomes matter most after pilot success—licensing, internal scale-up, handoff to manufacturing, or sale to a prime? Options: License/IP transfer, Internal scale-up to production, Tech transfer to manufacturer, Handshake to prime contractor, Spin-out / commercialization
    • How would you like lessons learned and failure modes documented during the program? Options: Weekly technical notes, Structured lessons-learned deliverable, Real-time issue tracker access, Final consolidated report, Combination

    Hidden Gates: Facilities, Security and Practical Constraints

    • Do you expect work to be done in our facilities, yours, or a mix—and what is the real barrier to each option? Options: All in our facilities, All in your facilities, Hybrid (both), Undecided
    • Which accreditations or lab certifications are required for this work? Options: ISO 17025, GLP, Biosafety level (specify), NIST traceability, DoD/government accreditation, None required, Other
    • What security clearances or background requirements must on-site staff meet? Options: Public trust / policy, Secret, Top Secret/SCI, No clearance needed, Facility access only
    • Are there chain-of-custody, sample handling, or disposal rules we should plan for?
    • Do you have constraints on shipping samples internationally or between facilities? Options: Yes—export controls apply, Yes—biosamples restricted, No constraints, Unsure / need to check
    • Would you want joint site visits and walkthroughs before the SOW is finalized? Options: Yes—essential, Helpful but not necessary, No

    Money, Contracts and Continuity—The Practical Tradeoffs

    • If the program discovers additional work is required to meet success signals, who would fund the incremental scope? Options: Client will fund, Jointly decide funding, Contingent on re-bid, Unclear / need approval
    • Which commercial models are acceptable to you for a pilot? Options: Fixed-price pilot, Milestone-based payments, Time & materials with cap, Hybrid (T&M + milestone), Other
    • What payment terms and invoicing cadence do you typically accept? Options: Net 30, Net 45, Net 60, Upfront deposit + milestones, Government-specific terms
    • How important is having staffing continuity (named PIs or technical leads committed for the program duration)? Options: Mandatory, Very important, Nice to have, Not necessary
    • What procurement or contracting hurdles should we expect (e.g., flow-down clauses, FAR/DFARS requirements)?
    • Have you worked with CRO-style research contracts before and what contract clause caused the most negotiation time?

    The One Critical Question (Pilot Focus & Next Steps)

    • What is the single critical technical question the pilot must answer to justify continued investment?
    • What would be the minimum viable set of experiments or milestones that would convincingly answer that question?
    • What is your target pilot duration and are there immovable windows for tests or samples? Options: 2–4 weeks, 4–8 weeks, 2–3 months, 3–6 months, Flexible
    • What deliverables do you need at pilot close to make a Go/No‑Go decision (e.g., raw data, independent report, prototype, test certificate)? Options: Raw datasets + metadata, Independent accredited test certificate, Prototype and build instructions, Technology transfer package, Executive summary + recommendations
    • What would make you say ‘we should start this pilot next week’—what factors must align?
    • What's the best next step right now to move this conversation forward? Options: Schedule technical deep-dive, Request draft SOW and budget, Facility walkthrough, Pilot proposal within 2 weeks, Other
  2. Solution Experience

    Use the customer’s critical technical question and failure modes to map a pilot feasibility path that confirms outcomes and de‑risking milestones.

    Experience Meetings

    • Solution Experience Kickoff — Problem & Success Signals
    • Failure Modes & Acceptance Criteria Workshop
    • Pilot Feasibility Plan — Experiments & De-risking Milestones
    • Technical Feasibility Review — Tools, Data & Staffing
    • Pilot Approval & Governance Gate
    • Ensure a contingency plan and escalation path are in place before pilot start.
    • Document necessary lab, security, and data requirements to execute the pilot.
    • Ensure each milestone's success is directly tied to reducing the stated consequence and proving the future state.
    • Seller to deliver a Pilot Experiment Matrix (experiments, success thresholds, measurement plan) within 3 business days.
    • Customer to confirm experimental constraints (e.g., sample limits, access windows) and approve the milestone sequence.
    • Reserve required lab time and instrumentation for the first milestone and confirm security/clearance needs.
    • Draft a preliminary pilot budget and resource list for customer review.
    • Confirm Lab & Facility Fit
    • Confirm lab and instrument availability and any constraints that would affect execution.
    • Agree a defensible data capture, validation, and custody process for pilot evidence.
    • Establish staffing assignments and a continuity plan to avoid knowledge loss.
    • Introductions & Meeting Objectives
    • Seller to confirm instrument reservation times and calibration schedules.
    • Assign named personnel (primary and backup) for each experiment and publish contact list.
    • Define and publish the data schema, storage location, and access controls for pilot results.
    • Customer and seller to agree contingency cost cap and decision triggers for invoking contingency.
    • Recap: Current State, Consequence, Future State
    • Obtain formal approval to execute the pilot with agreed scope, metrics, and milestones.
    • Establish governance structure, reporting cadence, and decision owners for go/no-go gates.
    • Ensure commercial and legal items that block execution are identified and either resolved or scheduled for resolution.
    • Customer to sign the pilot SOW and release initial funding or formal go-ahead.
    • Seller to publish the Pilot Execution Plan (schedule, owners, experiment matrix) and calendar invites for milestone reviews.
    • Legal/commercial owners to resolve any outstanding IP or licensing items flagged before the first milestone.
    • Set the first milestone review date and required evidence package to be delivered.
    • Produce a single-sentence Current State statement agreed by customer and seller.
    • Document measurable consequences (cost, time, risk) tied to the current state.
    • Agree a one-sentence Future State (outcome) the pilot must validate.
    • Confirm the critical technical question that the pilot will answer and required pre-work.
    • Owner to publish the agreed one-sentence Current State to the shared workspace.
    • Customer to provide data to quantify consequence (costs, schedule impacts, failure rates) within 3 business days.
    • Seller to draft the one-sentence Future State and circulate for confirmation.
    • Assign owners and deadlines for pre-work items (documents, samples, access).
    • Review Current State, Consequence, and Future State
    • Create a prioritized failure-mode list mapped to program impact.
    • Produce measurable pass/fail acceptance criteria for top failure modes.
    • Agree on measurement methods and required evidence for validation.
    • Customer validates that passing the defined metrics equates to achieving the future state.
    • Seller to produce a Failure Mode Matrix (mode, consequence, likelihood, acceptance metric) and share within 48 hours.
    • Customer to confirm or adjust ranked priorities for failure modes.
    • Assign owners for each measurement method and note any required third-party instrumentation or lab needs.
    • Define data format and storage location for evidence collected during the pilot.
    • Restate Critical Question & Top Failure Modes
    • Produce an experiment matrix where each test maps to a failure mode and an acceptance metric.
    • Agree a milestone schedule with explicit go/no-go criteria.
    • Experiment Matrix: Test -> Metric -> Expected Outcome
    • Review Pilot Plan & Milestones
    • Craft one-sentence Current State
    • Instrumentation, Calibration & Data Capture Plan
    • Brainstorm Failure Modes
    • Staffing & Continuity Plan
    • Quantify the Consequence
    • Commercial & Legal Pre-checks (IP, Licensing, Budget)
    • Define De-risking Milestones & Go/No-Go Gates
    • Prioritize by Impact and Likelihood
    • Governance, Reporting Cadence & Escalation
    • Resource, Lab, Security & Data Needs
    • Define one-sentence Future State (Outcome)
    • Define Measurable Acceptance Criteria
    • Risk Controls & Contingency Resources
    • Final Validation & Sign-off Question
  3. Solution Scope

    Define pilot and phased R&D scope: objectives, deliverables, acceptance criteria, lab/security requirements, staffing, and timeline.

    Scope Configuration

    • Fabricate Functional Prototype
    • Run Accredited Environmental Tests
    • Perform ISO/IEC 17025 Chemical Analyses
    • Execute Autonomous Systems Field Trials
    • Build Pilot Production Line
    • Perform Accelerated Life Testing
    • Execute GMP‑Compliant Assay Runs
    • Assemble and Validate Sensor Integration
    • Perform Materials Characterization (SEM/XRD)
    • Deliver Manufacturing-Ready Engineering Drawings
    • Produce Technology Transfer Package
    • Run Failure Reproduction Test Campaign

    Scope

    Fabricate Functional Prototype

    • Do you need a single breadboard prototype or multiple iterated prototypes? Options: Single prototype, Multiple iterations (2-3), Multiple iterations (4+), Undecided
    • What are the primary objectives for the prototype (select all that apply)? Options: Functional validation, Form/fit assessment, User evaluation, Manufacturability study, Regulatory submission, Other
    • What fidelity is required for the prototype (mechanical, electrical, software)? Describe required performance targets.
    • What materials, finishes, or vendor-supplied components must be used or avoided?
    • Do you require documentation and deliverables (e.g., BOM, assembly instructions, test reports)? Options: BOM and cost estimate, Assembly instructions, Functional test report, None/just hardware
    • What is the target delivery timeline for the prototype effort? Options: 2-4 weeks, 4-8 weeks, 8-12 weeks, 12+ weeks

    Run Accredited Environmental Tests

    • Which accredited environmental standards or test methods are required? Options: MIL-STD-810, IEC 60068, ASTM, Customer-specified protocol, Other
    • What sample types and quantities will you provide for testing? Options: Prototype units, Production samples, Materials only, Subassemblies, Specify in free text
    • Which environmental conditions must be exercised (temperature, vibration, shock, humidity, salt fog, EMI/EMC)? Options: Temperature, Vibration, Shock, Humidity/condensation, Salt fog/corrosion, EMI/EMC, Other
    • Is an accredited test report/certificate required for procurement or regulatory submission? Options: Yes, certificate required, Report only (non-accredited), No formal report required
    • Are there packing, handling, or fixture constraints for the test samples (e.g., explosive, classified, sterile)? Options: Yes - special handling, No special handling, TBD (will advise)
    • What is the expected schedule window for testing and how will test failures be handled (retest, modify, cancel)?

    Perform ISO/IEC 17025 Chemical Analyses

    • Which chemical analyses or assays under ISO/IEC 17025 accreditation do you require? Options: Contaminant quantification, Material composition, Residual solvents, Potency/assay, Other
    • What sample matrix and quantity are available (solid, liquid, gas; mass/volume)?
    • Are chain-of-custody, cold chain, or traceability controls required for samples? Options: Yes - chain-of-custody required, Cold chain required, No special requirements
    • Do results need to be accompanied by method validation, uncertainty, and LOQ/LOD reporting? Options: Yes - full validation metrics, Yes - basic uncertainty, No, summary results only
    • Is pre-approved SOP/method required or should the lab propose methods? Options: We will provide SOP/method, Lab to propose validated method, Hybrid (we provide references)
    • What turnaround time do you require for analysis and certified reporting? Options: 48-72 hours, 1-2 weeks, 2-4 weeks, Flexible

    Execute Autonomous Systems Field Trials

    • What autonomy function(s) must be validated during field trials (navigation, perception, control, swarm/cooperative behaviors)? Options: Navigation/localization, Perception/object detection, Control/stability, Path planning, Swarm/cooperative
    • What operating environment and constraints apply (urban, rural, maritime, GPS denied, classified airspace)? Options: Urban, Rural, Maritime, Indoor/GPS-denied, Restricted/controlled airspace, Other
    • How many vehicles/platforms and what configuration (fully integrated, sensor-only payload, software-in-the-loop)?
    • What safety, regulatory, or range approvals are required before trials (NOTAM, flight waivers, range access)? Options: Flight waivers/NOTAM, Range safety briefings, Regulatory approvals needed, None/applicant will advise
    • What data products and telemetry must be collected and delivered (raw sensor logs, annotated video, performance metrics)? Options: Raw sensor logs, Annotated video, Performance metrics, Health/diagnostics logs, Other
    • What are success criteria and acceptable failure modes for the field trial?

    Build Pilot Production Line

    • What annualized throughput or batch size is the pilot line expected to achieve? Options: <100 units/month, 100-1,000 units/month, 1,000-10,000 units/month, Custom/describe
    • Which production processes must be included on the pilot line (assembly, soldering, coating, CNC, molding, test/QA)? Options: Manual assembly, Automated assembly, Soldering/SMT, Molding/overmolding, CNC/precision machining, In-line test/QA
    • What quality standards or certifications must the pilot line meet (ISO 9001, AS9100, GMP)? Options: ISO 9001, AS9100, GMP, Customer-specific QMS, None
    • Will the pilot line require supplier-managed components or fully in-house fabrication? Options: In-house fabrication, Supplier-managed subassemblies, Hybrid
    • What staffing model do you expect for the pilot (operator count, engineers, QC)?
    • What is the target timeline from line design to first article availability? Options: 4-8 weeks, 8-16 weeks, 16-24 weeks, 24+ weeks

    Perform Accelerated Life Testing

    • Which accelerated stressors are required (temperature cycling, HALT, vibration, humidity, UV)? Options: Temperature cycling, HALT, Vibration, Humidity, UV/solar exposure, Other
    • What end-of-life criteria or failure thresholds define test completion?
    • How many samples and what lot distribution will be provided for ALT? Options: 1-3 samples, 4-10 samples, 10+ samples, Specify in free text
    • Do you require environmental chamber traceability, calibrated sensors, and time-temp logs with the report? Options: Yes - full calibration traceability, Basic logging only, No requirements specified
    • Should results include Weibull/MTTF modeling or statistical life projections? Options: Yes - Weibull/MTTF, No - pass/fail only, Discuss options
    • What turnaround and contingency plan do you expect if units fail early in ALT?

    Execute GMP‑Compliant Assay Runs

    • What assay type and throughput are required (ELISA, PCR, potency, stability)? Options: ELISA, qPCR/RT-PCR, Potency assay, Stability testing, Other
    • Do samples require controlled chain-of-custody, biosafety level handling, or controlled substances licensing? Options: Chain-of-custody required, Biosafety handling required, Controlled-substance license required, No special requirements
    • Are validated methods and GMP documentation (batch records, SOPs) required to accompany results? Options: Yes - full GMP documentation, Method validation only, No, research-grade reporting
    • What release criteria and acceptance ranges will you accept for assay outcomes?
    • What sample volumes/quantities and stability/storage conditions apply?
    • What turnaround time is required and is on-site inspection or audit requested? Options: 48-72 hours, 1-2 weeks, 2-4 weeks, On-site audit required

    Assemble and Validate Sensor Integration

    • Which sensors and interfaces must be integrated (camera, lidar, IMU, chemical sensor, CAN, Ethernet)? Options: Camera, Lidar, IMU/INS, Chemical sensor, CAN/LIN, Ethernet/ROS
    • What validation tests are required (latency, accuracy, calibration, environmental robustness)? Options: Latency/performance, Accuracy/calibration, Thermal/vibration robustness, EMI susceptibility, Other
    • Do sensors require custom firmware, drivers, or middleware integration (ROS nodes, SDKs)? Options: Custom firmware, Driver integration, Middleware/ROS nodes, No software work required
    • What are the acceptance criteria for integrated sensor performance?
    • Will integration require mechanical housings, connectors, or environmental sealing? Options: Yes - enclosures/sealing, Standard connectors only, TBD
    • What deliverables are required (calibration reports, source code, validation test logs)? Options: Calibration reports, Source code/artifacts, Validation test logs, Integration documentation

    Perform Materials Characterization (SEM/XRD)

    • Which characterization techniques are required (SEM, XRD, EDS, TEM, AFM)? Options: SEM, XRD, EDS, TEM, AFM, Other
    • What sample preparation constraints exist (coating, cross-sectioning, vacuum compatibility)?
    • How many specimens and from which lot(s) will be submitted? Options: Single specimen, 3-5 specimens, 6-20 specimens, 20+ specimens
    • Do you require quantitative phase analysis, particle size distribution, or elemental mapping? Options: Phase analysis (XRD), Particle size distribution, Elemental mapping (EDS), Topography (AFM/TEM)
    • Is an accredited or traceable report required, including instrument calibration details? Options: Yes - accredited/traceable report, Standard lab report, No report required
    • What timeline is required for characterization and are destructive methods acceptable? Options: 48-72 hours, 1-2 weeks, 2-4 weeks, Destructive methods acceptable, Destructive methods not acceptable

    Deliver Manufacturing-Ready Engineering Drawings

    • What drawing standards and formats are required (GD&T per ASME Y14.5, CAD format: STEP, SolidWorks)? Options: ASME Y14.5 (GD&T), ISO drawing standards, STEP files, Native CAD (SolidWorks, Creo), Other
    • Which parts require drawings versus assembly-level drawings and tolerances?
    • Do you require supplier-ready packaging, fabrication notes, and critical-to-quality callouts? Options: Yes - supplier-ready, Fabrication notes only, No packaging/notes required
    • Should drawings include manufacturing process recommendations (surface finish, heat treat, coatings)? Options: Yes - include recommendations, No - drawings only, Discuss per-part
    • What release process do you require for drawings (e.g., engineering review, signoff by customer)? Options: Vendor release after internal QA, Customer signoff required, Iterative review cycle desired
    • What is the target delivery schedule for full drawing package and bill of materials? Options: 2-4 weeks, 4-8 weeks, 8-12 weeks, Custom
  4. Mutual Commit

    Resolve commercial and legal terms including IP/licensing, milestone payments, staffing continuity commitments, and governance/escalation.

    Agreement Modules

    • Statement of Work (SOW)
    • Master Services Agreement (MSA)
    • Non-Disclosure Agreement (NDA)
    • IP and Licensing Agreement
    • Payment & Milestone Schedule
    • Staffing Continuity & Key Personnel Commitment
    • Governance, Escalation & Change Control
    • Acceptance Criteria & Test Protocols
    • Security, Facility Access & Accreditation Addendum
    • Data Management, Delivery & Technology Transfer
    • Export Controls & Regulatory Compliance
    • Insurance, Indemnity & Liability Schedule
    • Audit & Progress Reporting Rights
    • IP/Deliverable Escrow Agreement
  5. Deployment

    Plan and execute experiments, prototype builds, testing, data deliveries, and technology‑transfer activities with owners and timelines.

  6. Success

    Verify outcomes against success signals, finalize transfer documentation, capture lessons learned, and track issues for follow‑on work.

    Success Reviews

    • Outcome Verification Workshop
    • Final Technology Transfer & Documentation Handoff
    • Lessons Learned & Process Improvement Retrospective
    • Open Issues Triage & Follow‑On Work Planning
    • Executive Closeout & Strategic Review

    Issues & Enhancements

    • Create backlog entries for all triaged items in the agreed tracking tool with owners and due dates.
    • Ensure the customer receives a complete, usable transfer package that enables independent follow-on work.
    • Assign definitive owners for post-handoff support and training and agree a training schedule.
    • Resolve any outstanding IP/licensing record items required for handover.
    • Deliver the finalized documentation package to the agreed secure repository and confirm receipt.
    • Schedule and run the committed training sessions and capture attendance and feedback.
    • Log any residual documentation gaps and assign rapid-closure owners with deadlines.
    • Retrospective Objectives & Rules
    • Document an evidence-backed lessons learned report covering technical, operational, and contractual elements.
    • Prioritize a small set of high-impact process improvements with owners and deadlines.
    • Agree on how lessons will be shared internally and with program stakeholders.
    • Publish a formal lessons learned report including root-cause notes, suggested fixes, and owners.
    • Update internal playbook/SOPs where agreed and notify teams of mandatory changes.
    • Schedule a check-in to review progress on improvement actions in 30/60/90 days.
    • Review Open Issue Log
    • Agree a prioritized, risk‑ranked backlog of open issues with remediation owners and target dates.
    • Define candidate follow-on projects with clear objectives and preliminary budgets to enable rapid proposal creation.
    • Establish criteria for closing issues and criteria for escalation into funded follow-on work.
    • Introductions & Objectives
    • Draft preliminary statements of work for follow-on scope candidates and circulate for budgetary review.
    • Schedule focused technical deep-dive sessions for the top three high-risk items.
    • Executive Summary of Outcomes
    • Receive executive acknowledgement of program outcomes and a decision on pursuing follow-on work or scale-up.
    • Complete commercial closeout checklist including final payments and contract records.
    • Confirm commitments for continuity, escalation contacts, and sponsor-level owners for follow-on initiatives.
    • Issue the executive sign-off document and archive in contract records.
    • Finalize any remaining commercial closeout items (invoices, change orders) and confirm payment schedule.
    • Schedule a strategic kickoff for approved follow-on work and assign executive sponsors.
    • Confirm which deliverables meet the agreed success signals and record formal acceptance where appropriate.
    • Produce a prioritized remediation list for any gaps with owners and dates.
    • Ensure both parties have the same understanding of current state, consequences, and next steps.
    • Publish an acceptance record listing accepted deliverables and any conditional items, with signatures.
    • Create remediation tasks for each gap, assign owners, and set target completion and re-test dates.
    • Share raw data packages and provenance notes referenced during the walkthrough to the customer's secure repository.
    • Handoff Overview & Scope
    • Current State Statement
    • Documentation Package Review
    • Business Impact & Cost/Consequence Review
    • Prioritization & Risk Assessment
    • Synopsis of Project Timeline & Outcomes
    • Technical Triage of Top Risks
    • Risk/Continuity & Key Personnel Commitments
    • Consequence Framing
    • What Went Well (Evidence-Based)
    • Training & Knowledge Transfer Plan
    • What Didn’t Work & Root Cause Analysis
    • Data Formats, Access & Long‑term Storage
    • Commercial Closeout Items
    • Define Follow-On Scope Candidates
    • Success Signals & Acceptance Criteria Review
    • Prioritize Improvements & Assign Owners
    • Decision: Immediate Fix vs Phase Work
    • Strategic Roadmap & Decision on Next Steps
    • Evidence Walkthrough (Data & Artifacts)
    • IP, Licensing & Records Review
    • Gap Analysis & Root Cause Notes
    • Update Playbook and Next Steps
    • Action Plan & Backlog Creation
    • Handoff Acceptance & Checklist Sign-off
    • Final Sign-offs & External Communications
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.